Browse By Person: Jeet, Varinder
|Up a level|
Group by: Item Type | Date
Number of items: 9.
Jeet, Varinder (2014) Therapeutic options for metastatic castration resistant prostate cancer : has the situation improved? In Morais, Christudas (Ed.) Advances in Drug Resistance Research. NOVA Science Publishers, New York USA, pp. 137-154.
Tevz, Gregor, McGrath, Sean, Demeter, Ryan, Magrini, Vincent, Jeet, Varinder, Rockstroh, Anja, et al. (2016) Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer. Molecular and Cellular Endocrinology, 420, pp. 159-168.
Jeet, Varinder, Tevz, Gregor, Lehman, Melanie, Hollier, Brett, & Nelson, Colleen (2014) Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells. Endocrine Related Cancer, 21(5), pp. 723-737.
Jeet, Varinder, Russell, Pamela J., Verma, Nirupama D., & Khatri, Aparajita (2012) Targeting aurora kinases : a novel approach to curb the growth and chemoresistance of androgen refractory prostate cancer. Current Cancer Drug Targets, 12(2), pp. 144-163.
Jongbloed, Sarah L., Kassianos, Andrew J., McDonald, Kylie J., Clark, Georgina J., Ju, Xinsheng, Angel, Catherine E., et al. (2010) Human CD141(+) (BDCA-3)(+) dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. Journal of Experimental Medicine, 207(6), pp. 1247-1260.
Jeet, Varinder, Russell, Pamela, & Khatri, Aparajita (2010) Modeling prostate cancer: a perspective on transgenic mouse models. Cancer and Metastasis Reviews, 29(1), pp. 123-142.
Jeet, Varinder, Ow, Kim, Doherty, Eboney, Curley, Ben, Russell, Pamela, & Khatri, Aparajita (2008) Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer. The Prostate, 68(5), pp. 548-562.
Tevz, Gregor, Hossain, Akther, Bock, Nathalie, Jeet, Varinder, Bathgate, Ross A., Williams, Elizabeth D., et al. (2015) Impeding the adaptive response of prostate cancer to androgen targeted therapies with relaxin receptor antagonist. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Jeet, Varinder, Rockstroh, Anja, Lehman, Melanie, & Nelson, Colleen C. (2015) Investigating the role of a potential angiogenic target, YKL40, for the treatment of metastatic prostate cancer. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.